<unk>  is a antiglaucoma, prostaglandin and ophthalmologic agent that is FDA approved for the treatment of for lowering of intraocular pressure in patients with open-angle glaucoma or ocular hypertension.   Common adverse reactions include increased hair growth of eyelash, abnormal vision, burning sensation in eye, disorder of eyelid, disorder of lacrimal system, dry eyes, hyperemia of surface of eye and itching of eye.
Unoprostone
Dinoprostone
Epoprostenol
Latanoprost
Carboprost
Travoprost
Latanoprostene bunod
Flurandrenolide